July 28, 2020
Israeli medical imaging company Nano-X announced last Tuesday its closing of a Series B Round in which it had raised US$110 million!
The company developed an innovative X-Ray based imaging device, that produces a 3D scan. The company’s technology significantly reduces the costs of similar medical imaging existing in the market.
Nano-X is represented by Adv. Ian Rostowsky, partner and co-head of our Hi-Tech and Venture Capital Department, as well as Adv. Ayelet Torem, a partner in our Hi-Tech and Venture Capital Department and head of our Global Markets. Also assisted in the transaction was Adv. Kobi Vinekrantz, of our Hi-Tech and Venture Capital Department.
For the full article in Hebrew please click here.